There is no doubt that Ocean Biomedical Inc (OCEA) ticks all the boxes.

With 25.4 million shares changed hands, the volume of the stock remained lighter than its average volume of 30.12 million shares. The 52-week range on OCEA shows that it touched its highest point at $7.79 and its lowest point at $0.11 during that stretch. It currently has a 1-year price target of $18.50. Beta for the stock currently stands at 1.37.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OCEA was down-trending over the past week, with a drop of -20.33%, but this was down by -75.00% over a month. Three-month performance dropped to -84.78% while six-month performance fell -90.37%. The stock lost -80.89% in the past year, while it has lost -81.01% so far this year.

Float and Shares Shorts:

At present, 34.87 million OCEA shares are outstanding with a float of 10.41 million shares on hand for trading.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. Over the past year, revenue came in at $0.00 while operating income stood at -$25.08M. EBITDA for the full year was -$25.08M.

Analysts Ratings:

In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.89 being high and -$0.89 being low. For OCEA, this leads to a yearly average estimate of -$0.89. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.